This company has been operating in the pharmaceutical industry for over five decades, demonstrating a strong commitment to healthcare solutions. They specialize in manufacturing finished dosage formulations, biosimilars, and API/DC granules, catering to diverse needs within the healthcare market. Their focus on research and development drives innovation and ensures high-quality products, while their commitment to regulatory compliance ensures patient safety and efficacy. They possess extensive experience in the pharmaceutical industry, with a global reach and a strong presence in key regions like Asia and North America. Their production lines are compliant with EU and US GMP standards, reflecting their dedication to quality and adherence to international best practices. Key therapy areas include oncology, cardiology, and other areas where biosimilars are widely used. They offer a variety of dosage forms including solids, liquids, and injectables. While specific product patents are not explicitly mentioned, their focus on innovation and research suggests they actively pursue intellectual property protection for their offerings.

This pharmaceutical company specializes in the manufacturing and marketing of a broad range of finished pharmaceutical formulations. They focus on niche therapeutic segments, producing capsules, creams, and ointments. Their EU GMP and TGA-approved manufacturing facility adheres to strict quality standards like FDA India, CGMP under Schedule 'M', and WHO-GMP certification. The company's products are distributed across key markets in Europe, Southeast Asia, Latin America, the Middle East, and Africa. They emphasize research and development, aiming to become a leading pharmaceutical player both domestically and globally.